Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Market Analysis and Insights: Global Therapeutic Nuclear Medicines Market
In 2019, the global Therapeutic Nuclear Medicines market size was US$ 1027.8 million and it is expected to reach US$ 2473.9 million by the end of 2026, with a CAGR of 13.8% during 2021-2026.
Global Therapeutic Nuclear Medicines Scope and Market Size
Therapeutic Nuclear Medicines market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Therapeutic Nuclear Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.
Segment by Type, the Therapeutic Nuclear Medicines market is segmented into
Radium-223
Lutetium-177
Iodine-131
Other
Segment by Application, the Therapeutic Nuclear Medicines market is segmented into
Thyroid
Bone Metastasis
Lymphoma
Other
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Therapeutic Nuclear Medicines market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Therapeutic Nuclear Medicines product introduction, recent developments, Therapeutic Nuclear Medicines sales by region, type, application and by sales channel.
The major companies include:
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Market Analysis and Insights: Global Therapeutic Nuclear Medicines Market
In 2019, the global Therapeutic Nuclear Medicines market size was US$ 1027.8 million and it is expected to reach US$ 2473.9 million by the end of 2026, with a CAGR of 13.8% during 2021-2026.
Global Therapeutic Nuclear Medicines Scope and Market Size
Therapeutic Nuclear Medicines market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Therapeutic Nuclear Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.
Segment by Type, the Therapeutic Nuclear Medicines market is segmented into
Radium-223
Lutetium-177
Iodine-131
Other
Segment by Application, the Therapeutic Nuclear Medicines market is segmented into
Thyroid
Bone Metastasis
Lymphoma
Other
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
and Therapeutic Nuclear Medicines Market Share AnalysisTherapeutic Nuclear Medicines market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Therapeutic Nuclear Medicines product introduction, recent developments, Therapeutic Nuclear Medicines sales by region, type, application and by sales channel.
The major companies include:
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
